Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer

NCT04431791 · clinicaltrials.gov ↗

UNKNOWN

Status

268

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: Regorafenib
DRUG: Fruquintinib

Sponsor

Peking University